Advancing Prostate Cancer Detection: The Role of AI and Blood-Based Screening

by RMDM | Mar 5, 2025 | News, Diagnostics Activity

The recent breakthrough in prostate cancer screening with the AI-powered test developed by EDX Medical Group represents a significant advancement in early cancer detection. By analysing more than 100 biological markers through blood and urine samples, this test could...

NHS Backlogs, Less Rhetoric and More Solutions by Dr. Letizia Gulino, Head of Science and Technology RMDM

by RMDM | Jan 17, 2025 | News, Diagnostics Activity

We are witnessing a crucial moment for the NHS as it promises to reduce waiting lists and deliver timely care. This commitment resonates with patients and healthcare professionals. However, while the intentions behind these proposals are laudable, critical questions...

Reforming Prostate Cancer Testing: Chris Hoy’s Urgent Appeal for Change

by RMDM | Nov 15, 2024 | News, Diagnostics Activity

Cancer is a major global health concern, but it’s typically associated with older age. However, in recent years, there has been a clear rise in younger individuals who have early-onset cancer. In this article, we will break down the findings of a study conducted in...

Government and Tech Innovators Unite to Advance Cancer Detection: The Potential of Pantum Detect

by RMDM | Oct 29, 2024 | News, Diagnostics Activity

In a recent press release, the UK government outlined an initiative to boost tech deals aimed at further innovating cancer diagnosis in the country. This plan follows the Darzi review, which highlighted the critical state of the NHS, particularly the urgent need to...

Darzi Report Findings: The Urgent Need for Innovative Technology in NHS Cancer Care

by RMDM | Sep 19, 2024 | News, Diagnostics Activity

In the House of Commons, Health Secretary Wes Streeting introduced a “national mission” to tackle key health challenges. Presenting the Darzi report, commissioned by the Labour government, he outlined the NHS’s ongoing struggles in the post-pandemic...